Pretraživanje
Prikaz rezultata 1-10 od 10
Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia
(Pergamon-Elsevier Science Ltd, Oxford, 2009)
Introduction: It is considered that high plasma levels of procarboxypeptidase U (proCPU or TAFI) can promote the development of thrombosis, but data comparing proCPU levels in thrombophilia carriers and healthy subjects ...
Evaluation of endogenous thrombin potential among patients with antithrombin deficiency
(Pergamon-Elsevier Science Ltd, Oxford, 2018)
Can anticoagulant therapy improve the outcome of pregnancy in thrombophilic women?
(Pergamon-Elsevier Science Ltd, Oxford, 2011)
Combined severe factor XII deficiency and homozygous factor V Leiden mutation in a patient with venous thrombosis
(Pergamon-Elsevier Science Ltd, Oxford, 2002)
Pregnancy loss and thrombotic complications during pregnancy and puerperium in women with coinheritance of factor V Leiden and FII G20210A mutation
(Pergamon-Elsevier Science Ltd, Oxford, 2005)
Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A
(Pergamon-Elsevier Science Ltd, Oxford, 2019)
The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications
(Pergamon-Elsevier Science Ltd, Oxford, 2019)
Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis ...
Influence of decreased fibrinolytic activity on venous thrombosis risk
(Pergamon-Elsevier Science Ltd, Oxford, 2016)
Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency
(Pergamon-Elsevier Science Ltd, Oxford, 2016)
The use of D-dimer with new threshold in diagnosis of venous thromboembolism in pregnancy
(Pergamon-Elsevier Science Ltd, Oxford, 2009)